TuHURA Biosciences, Inc.
HURA
$3.22
$0.3110.65%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | ||
---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | |
Total Other Revenue | -- | -- | -- | -- | |
Total Revenue | -- | -- | -- | -- | |
Cost of Revenue | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | |
SG&A Expenses | 63.44% | -- | -- | -- | |
Depreciation & Amortization | -- | -- | -- | -- | |
Other Operating Expenses | -- | -- | -- | -- | |
Total Operating Expenses | 45.16% | -- | -- | -- | |
Operating Income | -45.16% | -- | -- | -- | |
Income Before Tax | -60.20% | -- | -- | -- | |
Income Tax Expenses | -- | -- | -- | -- | |
Earnings from Continuing Operations | -60.20% | -- | -- | -- | |
Earnings from Discontinued Operations | -- | -- | -- | -- | |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
Minority Interest in Earnings | -- | -- | -- | -- | |
Net Income | -60.20% | -- | -- | -- | |
EBIT | -45.16% | -- | -- | -- | |
EBITDA | -46.10% | -- | -- | -- | |
EPS Basic | 31.59% | -- | -- | -- | |
Normalized Basic EPS | 43.11% | -- | -- | -- | |
EPS Diluted | 31.66% | -- | -- | -- | |
Normalized Diluted EPS | 43.11% | -- | -- | -- | |
Average Basic Shares Outstanding | 123.73% | -- | -- | -- | |
Average Diluted Shares Outstanding | 123.73% | -- | -- | -- | |
Dividend Per Share | -- | -- | -- | -- | |
Payout Ratio | -- | -- | -- | -- |